ENBIO Co., Ltd. (KOSDAQ:352940)
2,450.00
-10.00 (-0.41%)
At close: Apr 21, 2025, 3:30 PM KST
ENBIO Revenue
In the year 2024, ENBIO had annual revenue of 35.65B KRW with 4.79% growth. ENBIO had revenue of 5.17B in the quarter ending December 31, 2024, with 13.56% growth.
Revenue
35.65B
Revenue Growth
+4.79%
P/S Ratio
0.77
Revenue / Employee
445.68M
Employees
80
Market Cap
27.55B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35.65B | 1.63B | 4.79% |
Dec 31, 2023 | 34.02B | -215.53M | -0.63% |
Dec 31, 2022 | 34.24B | 773.80M | 2.31% |
Dec 31, 2021 | 33.47B | -1.10B | -3.17% |
Dec 31, 2020 | 34.56B | 827.52M | 2.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 66.19T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 175.23T |
Hanwha Aerospace | 11.24T |
Kia Corporation | 107.45T |
Celltrion | 3,557.30B |